About Congenital Myasthenia

Overview

Congenital myasthenia is a condition where individuals experience muscle weakness that gets worse with physical activity. This weakness often starts in early childhood, but it can also appear during adolescence or adulthood. The muscles most commonly affected are those in the face, like the ones controlling eyelids, eye movements, chewing, and swallowing. However, any skeletal muscles used for movement can also be impacted. Infants with this condition may have trouble feeding and delays in crawling or walking. The severity of muscle weakness varies among individuals, with some having mild weakness while others are unable to walk. In severe cases, breathing difficulties may occur during fevers or infections, leading to short pauses in breathing that can cause a bluish tint to the skin or lips.

Causes and Risk Factors

Mutations in genes like CHRNE, RAPSN, CHAT, COLQ, and DOK7 can cause congenital myasthenia. These genes affect the neuromuscular junction, where nerve cells and muscle cells communicate to trigger muscle movement.

Non-modifiable risk factors are risk factors that cannot be changed. Non modifiable risk factors for congenital myasthenia include genetic defects that lead to impaired neuromuscular transmission.

Symptoms

The most common early symptoms of congenital myasthenia include:

• Respiratory insufficiency with sudden pauses in breathing
• Bluish appearance of the skin or lips
• Feeding difficulties
• Choking spells
• Eyelid drooping
• Facial, bulbar, and generalized weakness

As congenital myasthenia progresses or reaches higher severity, other common symptoms may include abnormal muscle fatigability with difficulty in activities like running or climbing stairs, and delayed movement milestones.

Diagnosis

Commonly performed tests for diagnosing congenital myasthenia include:

• Imaging studies: This may involve computed tomography (CT), magnetic resonance imaging (MRI) scans of the central nervous system, echocardiogram, and abdominal ultrasound or CT scans.
• Genetic testing: These are blood tests for specific genetic mutations associated with congenital myasthenia.
• Neurophysiological studies: Single-fiber electromyography (SFEMG) and repetitive nerve stimulation study (RNS) can help diagnose neuromuscular junction defects and differentiate between different types of myasthenic syndromes.
• Molecular genetic testing: This is done through gene-targeted testing or next-generation sequencing (NGS) panel testing can provide a precise genetic diagnosis to guide treatment decisions and determine the specific subtype of congenital myasthenia.

If you have concerns about your baby’s health, it is best to consult with your health professional for personalized advice and guidance.

Treatment Options

The goals of treatment for congenital myasthenia aim to improve muscle strength and function, enhance neuromuscular transmission, and manage symptoms effectively. Treatments for congenital myasthenia include:

• Medications: Some common types of medication used in the treatment of Congenital Myasthenia include acetylcholinesterase inhibitors, which help increase the levels of acetylcholine at the neuromuscular junction, improving muscle contractions. Immunomodulatory therapies may also be prescribed to modulate the immune response in certain types of congenital myasthenia.
• Therapeutic procedures: Plasmapheresis or intravenous immunoglobulin therapy can be recommended to remove harmful antibodies or provide passive immunity, respectively, in specific cases of congenital myasthenia.
• Lifestyle behavior changes: This involves maintaining a balanced diet, regular exercise, and managing stress which can support overall health and well-being in individuals with congenital myasthenia. Physical therapy may also be advised to improve muscle strength and coordination.
• Therapies: Physical therapy or respiratory support if breathing difficulties are present may be suggested.
• Surgery: In certain subtypes of congenital myasthenia surgery may be recommended along with close monitoring of symptoms to adjust treatment plans accordingly.

Each of these approaches works towards achieving the treatment goals by addressing specific aspects of the condition and improving quality of life for individuals with congenital myasthenia.

Progression or Complications

Congenital myasthenia is a condition where muscle weakness worsens with physical activity. The weakness typically starts in early childhood but can also appear later. The severity of congenital myasthenia varies greatly among individuals. Some experience mild weakness, while others have severe weakness, making walking difficult. Facial muscles, including those controlling eyelids, eye movement, chewing, and swallowing, are often affected. Muscle weakness may lead to feeding difficulties and delayed motor skill development like crawling or walking.

Complications that commonly occur with congenital myasthenia include breathing difficulties, especially during fevers or infections. Severe cases may lead to apnea episodes, where breathing pauses temporarily and may lead to a bluish skin appearance (cyanosis). These complications can be life-threatening and require immediate medical attention.

Treatment aims to manage symptoms and improve quality of life rather than cure the condition completely. Treatment options that may be considered include:

• Medications like acetylcholinesterase inhibitors can help improve muscle strength and function.
• Physical therapy may also be beneficial to maintain muscle tone and flexibility.
• In severe cases, respiratory support might be necessary during acute episodes of breathing difficulty.

Regular monitoring by healthcare providers is essential to adjust treatment plans as needed and address any emerging complications promptly. It's important to work closely with healthcare professionals to develop a comprehensive treatment approach tailored to individual needs and ensure the best possible outcomes for those living with congenital myasthenia.